Spots Global Cancer Trial Database for mfolfox6 regimen
Every month we try and update this database with for mfolfox6 regimen cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 | NCT03618758 | Gastric Cancer ... Peritoneal Carc... Intraperitoneal... mFOLFOX6 | Paclitaxel mFOLFOX6 regime... | 20 Years - 79 Years | Seoul National University Bundang Hospital | |
| Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer | NCT05193292 | Colorectal Neop... Intestinal Neop... | Camrelizumab Trastuzumab XELOX regimen mFOLFOX6 regime... FOLFIRI regimen mXELIRI regimen mIRIS regimen | 18 Years - | Fudan University | |
| Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors | NCT03954704 | Advanced Solid ... | Dalutrafusp alf... mFOLFOX6 Regime... Dalutrafusp alf... | 18 Years - | Gilead Sciences | |
| FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer | NCT02226380 | Gastric Cancer Effects of Chem... Surgery | mFOLFOX6 regime... | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 | NCT03618758 | Gastric Cancer ... Peritoneal Carc... Intraperitoneal... mFOLFOX6 | Paclitaxel mFOLFOX6 regime... | 20 Years - 79 Years | Seoul National University Bundang Hospital | |
| Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer | NCT05193292 | Colorectal Neop... Intestinal Neop... | Camrelizumab Trastuzumab XELOX regimen mFOLFOX6 regime... FOLFIRI regimen mXELIRI regimen mIRIS regimen | 18 Years - | Fudan University | |
| Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer | NCT04310176 | Ras-mutated Met... | Bevacizumab mFOLFOX6 regime... mOXXEL regimen Valproic acid Capecitabine 5-fluorouracil | 18 Years - | National Cancer Institute, Naples | |
| QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety | NCT04233151 | Metastatic Colo... | QL1203 Placebo mFOLFOX6 regime... | 18 Years - | Qilu Pharmaceutical Co., Ltd. | |
| Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors | NCT03954704 | Advanced Solid ... | Dalutrafusp alf... mFOLFOX6 Regime... Dalutrafusp alf... | 18 Years - | Gilead Sciences | |
| A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer | NCT00779311 | Metastatic Colo... | sorafenib bevacizumab mFOLFOX6 regime... | 18 Years - | Accelerated Community Oncology Research Network | |
| Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors | NCT03954704 | Advanced Solid ... | Dalutrafusp alf... mFOLFOX6 Regime... Dalutrafusp alf... | 18 Years - | Gilead Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
